Phase I / II Gene Therapy Trial of Fanconi anemia patients with a new orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action - EUROFANCOLEN

Project Details

Description

summary not available
StatusFinished
Effective start/end date1/01/1331/12/18

Collaborative partners

  • Catalan Health Institute (Project partner)
  • Assistance publique - Hôpitaux de Paris (Project partner)
  • Deutsches Krebsforschungszentrum Heildeberg-German Cancer Research Center (Project partner)
  • Généthon. Centre de Recherche et d'applications sur les thérapies géniques (Project partner)
  • Université Paris Diderot, Paris 7 (PARIS7) (Project partner)
  • Servicio Madrileño de Salud (SERMAS) (Project partner)
  • Universitat Autònoma de Barcelona (UAB) (Project partner)
  • University College London (Project partner)

Funding

  • European Commission (EC): €5,380,160.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.